The U.S. Sanctions 'Hekimane Shargh' Company for Involvement in Iran's Chemical Weapons Development

The United States announced that it has placed the company 'Hekimane Shargh' on its sanctions list. Matthew Miller, spokesperson for the U.S. Department of State, stated in a statement on Friday, July 13, that the company has been sanctioned due to its involvement in the research and development program of chemical weapons for the Islamic Republic of Iran. According to the U.S. State Department's statement, this sanction is imposed under 'Executive Order 13382', which is designed to combat proliferators of weapons of mass destruction and their supporters. The U.S. has repeatedly urged the Islamic Republic of Iran to cooperate with the Chemical Weapons Convention. According to the U.S. State Department, this request was last raised at a meeting of the Executive Council of the Organization for the Prohibition of Chemical Weapons, but Tehran did not agree to these requests, leading to the new sanctions being imposed. The U.S. emphasizes its continued efforts to counter the threats posed by the Islamic Republic. The United States claims that Tehran has not fully disclosed its chemical weapons-related activities and facilities since 2018. As a signatory to the Nuclear Non-Proliferation Treaty (NPT), Iran is expected to adhere to its commitments under this treaty, which includes the ongoing inspections by the Agency at its nuclear facilities such as the Natanz and Fordow enrichment sites. Under the Joint Comprehensive Plan of Action (JCPOA), the monitoring and oversight scope of the Agency was expanded to include more facilities and activities. One significant aspect of this agreement was the Agency's oversight of the construction of centrifuges and the number of these uranium enrichment devices, as well as the process and volume of yellowcake production, which is further processed by enrichment centrifuges. The Iranian government canceled these two special monitoring aspects in February 2022, raising concerns about the establishment of clandestine enrichment facilities. In May 2021, several European countries separately announced that the Islamic Republic had recently made several attempts to acquire technology for a 'weapons of mass destruction' program. According to reports from security agencies in these countries, Iran has not ceased its 'efforts' to 'produce nuclear weapons' in violation of its commitments. The U.S. Department of State emphasized in its statement on July 13 that it will continue to counter any efforts by the Iranian regime to develop chemical weapons, including those that may be used by its proxy forces and partners; weapons that could support the destabilizing program of the Islamic Republic in inciting and prolonging conflicts worldwide. Hamas and Islamic Jihad in Gaza have long been accused of receiving weapons from Iran. Some Iranian political and military officials, as well as officials in these Palestinian organizations, have occasionally confirmed military cooperation. However, the Islamic Republic of Iran has been accused by Palestinian officials affiliated with Hamas of failing to show practical support for Palestinians during the ongoing war between the extremist group Hamas and Israel. The United States in 2024 also introduced the development of pharmaceutical materials as part of Iran's chemical weapons program and considered it a violation of the Nuclear Non-Proliferation Treaty. On the website of 'Hekimane Shargh', which has recently been placed on the U.S. Department of State's sanctions list, this company is introduced as a research company based in Isfahan. Its main activities are also described as the production of medicines and healthcare services in various fields. Iran has been a victim of chemical weapons itself, having been targeted multiple times by Iraqi forces during the eight-year war with Iraq.